NO20073699L - Stabile protaglandin-inneholdende preparater - Google Patents

Stabile protaglandin-inneholdende preparater

Info

Publication number: NO20073699L
Authority: NO; Norway
Prior art keywords: protaglandin; stable; prostaglandin; containing preparations; acid ester
Prior art date: 2005-01-20

Application number

NO20073699A

Other languages

English (en)

Norwegian (no)

Inventor

Ian Gardner Cameron Mcaffer

Peter Tasko

Victor Deaciuc

Michael Hagan

Hashem Heiati

Karen Kostick Jette

Gregory C Visor

Original Assignee

Breath Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-01-20

Filing date

2007-07-17

Publication date

2007-10-19

2007-07-17 Application filed by Breath Ltd filed Critical Breath Ltd

2007-10-19 Publication of NO20073699L publication Critical patent/NO20073699L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

NO20073699A 2005-01-20 2007-07-17 Stabile protaglandin-inneholdende preparater NO20073699L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0501192.9A GB0501192D0 (en)	2005-01-20	2005-01-20	Stable prostaglandin-containing compositions
PCT/US2006/001626 WO2006078659A2 (fr)	2005-01-20	2006-01-18	Compositions stables contenant de la prostaglandine

Publications (1)

Publication Number	Publication Date
NO20073699L true NO20073699L (no)	2007-10-19

Family

ID=34259405

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20073699A NO20073699L (no)	2005-01-20	2007-07-17	Stabile protaglandin-inneholdende preparater

Country Status (16)

Country	Link
US (2)	US8084501B2 (fr)
EP (1)	EP1843744A2 (fr)
JP (2)	JP2008528490A (fr)
KR (1)	KR20070094793A (fr)
CN (1)	CN101106973A (fr)
AU (1)	AU2006206649B2 (fr)
BR (1)	BRPI0606606A2 (fr)
CA (1)	CA2595237A1 (fr)
CZ (1)	CZ2007555A3 (fr)
GB (1)	GB0501192D0 (fr)
IL (1)	IL184111A0 (fr)
IS (1)	IS8665A (fr)
NO (1)	NO20073699L (fr)
NZ (1)	NZ556117A (fr)
WO (1)	WO2006078659A2 (fr)
ZA (1)	ZA200705428B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI394564B (zh) *	2006-09-21	2013-05-01	Alcon Res Ltd	自行保存型水性藥學組成物
US9394520B2 (en)	2006-12-08	2016-07-19	University Of Rochester	Expansion of hematopoietic stem cells
JP5297815B2 (ja) *	2007-01-26	2013-09-25	株式会社ポーラファルマ	医薬組成物
EP2123278B1 (fr) *	2007-02-07	2013-01-09	Teika Pharmaceutical Co., Ltd.	Préparation de gouttes ophtalmiques comprenant du latanoprost
JP2008247828A (ja) *	2007-03-30	2008-10-16	Wakamoto Pharmaceut Co Ltd	ラタノプロストを含有する水性医薬組成物。
EP2227213B1 (fr) *	2007-11-30	2012-08-29	Toltec Pharmaceuticals, Llc	Compositions et procédés pour traiter des infections vaginales et des biofilms vaginaux pathogènes
TWI544927B (zh)	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (fr) *	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Procédé et composition pour traiter l'hypertension oculaire et le glaucome
WO2010016044A1 (fr) *	2008-08-05	2010-02-11	University College Cork, National University Of Ireland, Cork	Traitement de la dégénérescence de la rétine
US20100087540A1 (en) *	2008-10-07	2010-04-08	R-Tech Ueno, Ltd.	Pharmaceutical composition
US20120232139A1 (en) *	2009-09-01	2012-09-13	Ryuji Ueno	Composition for ocular topical administration treatment ocular hypertension and glaucoma
EP2498784A2 (fr) *	2009-11-09	2012-09-19	Allergan, Inc.	Compositions pour l'amélioration de la pousse des cheveux
TWI478730B (zh) *	2009-12-03	2015-04-01	Alcon Res Ltd	眼科乳劑
US20120263803A1 (en) *	2011-04-12	2012-10-18	R-Tech Ueno, Ltd.	Aqueous ophthalmic composition
DE102011108948A1 (de) *	2011-07-29	2013-01-31	Achim Göpferich	Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
CN104208015A (zh) *	2013-05-29	2014-12-17	天津金耀集团有限公司	含有曲伏前列腺素和防腐剂的眼部制剂
PL3103439T3 (pl) *	2015-06-09	2019-12-31	Medproject Pharma-Entwicklungs- Und Vertriebsgesellschaft Mbh	Zdolny do tworzenia kropli oftalmiczny żel bimatoprostu
EP3643297A4 (fr)	2017-06-22	2021-03-17	Yonsung Fine Chemical Co., Ltd.	Composition ophtalmique pour le traitement du glaucome
JP2024516834A (ja) *	2021-04-30	2024-04-17	イノベントバイオロジクス（スーチョウ）カンパニー，リミティド	Ｏｘｍ３保存剤、ｏｘｍ３製剤および調製方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1366215A (en)	1916-08-05	1921-01-18	Vaporackumulator Ab	Supplementary power plant for electric centrals
US5165918A (en) *	1988-06-28	1992-11-24	Ciba-Geigy Corporation	Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
DE69105349T2 (de) *	1990-05-22	1995-04-06	Ueno Seiyaku Oyo Kenkyujo Kk	Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
CA2086874E (fr)	1992-08-03	2000-01-04	Renzo Mauro Canetta	Methodes d'administration du taxol
US5972991A (en)	1992-09-21	1999-10-26	Allergan	Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
AU665287B2 (en) *	1992-12-21	1995-12-21	Alcon Laboratories, Inc.	Prostaglandin combinations in glaucoma therapy
US5510383A (en)	1993-08-03	1996-04-23	Alcon Laboratories, Inc.	Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5545665A (en)	1993-12-28	1996-08-13	Allergan	Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US6011062A (en)	1994-12-22	2000-01-04	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5631287A (en)	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
AU7680096A (en) *	1995-12-22	1997-07-17	Alcon Laboratories, Inc.	Combinations of dp and fp type prostaglandins for lowering iop
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
SE9702681D0 (sv)	1997-07-10	1997-07-10	Pharmacia & Upjohn Ab	Method and composition for treatment of impotence
SE9702706D0 (sv)	1997-07-11	1997-07-11	Pharmacia & Upjohn Ab	Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
WO1999012899A1 (fr)	1997-09-09	1999-03-18	The Procter & Gamble Company	Procede de production d'analogues de prostaglandine f
US6646001B2 (en) *	1997-12-19	2003-11-11	Alcon Manufacturing, Ltd.	Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
US6235781B1 (en)	1998-07-14	2001-05-22	Alcon Laboratories, Inc.	Prostaglandin product
US6388128B1 (en)	1998-10-05	2002-05-14	Alcon Manufacturing, Ltd.	Stannane synthesis of prostanoids
US6417228B1 (en) *	1998-11-02	2002-07-09	Alcon Manufacturing, Ltd..	13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
SE9900025D0 (sv)	1999-01-08	1999-01-08	Synphora Ab	Method and composition for treatment of female sexual dysfunction
US6136846A (en)	1999-10-25	2000-10-24	Supergen, Inc.	Formulation for paclitaxel
JP3876355B2 (ja) *	2000-09-13	2007-01-31	参天製薬株式会社	点眼液
AU2001286210A1 (en)	2000-09-13	2002-03-26	Asahi Glass Company, Limited	Eye drops
US20030018079A1 (en) *	2000-11-13	2003-01-23	Richardson Helene	Treatment
US6743439B1 (en) *	2001-06-27	2004-06-01	Alcon, Inc.	Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
US7351404B2 (en) *	2002-02-04	2008-04-01	Allergan, Inc.	Method of enhancing hair growth
NO317079B1 (no) *	2002-08-02	2004-08-02	Maritime Hydraulics As	Stigerorstrekkanordning
US6864282B2 (en) *	2002-08-05	2005-03-08	Allergan, Inc.	9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
US20040076678A1 (en)	2002-08-21	2004-04-22	Sucampo Ag	Opthalmic solution
KR101253941B1 (ko)	2002-09-09	2013-04-16	산텐 세이야꾸 가부시키가이샤	라타노프로스트를 유효 성분으로 하는 투명한 점안액
US7074827B2 (en) *	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma

2005
- 2005-01-20 GB GBGB0501192.9A patent/GB0501192D0/en not_active Ceased
2006
- 2006-01-18 BR BRPI0606606-2A patent/BRPI0606606A2/pt not_active IP Right Cessation
- 2006-01-18 KR KR1020077016516A patent/KR20070094793A/ko not_active Withdrawn
- 2006-01-18 EP EP06718670A patent/EP1843744A2/fr not_active Withdrawn
- 2006-01-18 CN CNA2006800023897A patent/CN101106973A/zh active Pending
- 2006-01-18 JP JP2007552216A patent/JP2008528490A/ja active Pending
- 2006-01-18 CA CA002595237A patent/CA2595237A1/fr not_active Abandoned
- 2006-01-18 WO PCT/US2006/001626 patent/WO2006078659A2/fr not_active Ceased
- 2006-01-18 AU AU2006206649A patent/AU2006206649B2/en not_active Ceased
- 2006-01-18 NZ NZ556117A patent/NZ556117A/en not_active IP Right Cessation
- 2006-01-20 US US11/336,115 patent/US8084501B2/en not_active Expired - Fee Related
2007
- 2007-06-21 IL IL184111A patent/IL184111A0/en unknown
- 2007-07-03 ZA ZA200705428A patent/ZA200705428B/xx unknown
- 2007-07-17 NO NO20073699A patent/NO20073699L/no not_active Application Discontinuation
- 2007-08-02 IS IS8665A patent/IS8665A/is unknown
- 2007-08-16 CZ CZ20070555A patent/CZ2007555A3/cs unknown
2011
- 2011-11-17 US US13/298,400 patent/US20120065258A1/en not_active Abandoned
2012
- 2012-12-27 JP JP2012286362A patent/JP2013056948A/ja active Pending

Also Published As

Publication number	Publication date
IS8665A (is)	2007-08-02
US20060270735A1 (en)	2006-11-30
WO2006078659A8 (fr)	2007-08-30
GB0501192D0 (en)	2005-03-02
JP2008528490A (ja)	2008-07-31
EP1843744A2 (fr)	2007-10-17
WO2006078659A2 (fr)	2006-07-27
CA2595237A1 (fr)	2006-07-27
CZ2007555A3 (cs)	2007-10-10
WO2006078659A3 (fr)	2006-11-16
AU2006206649B2 (en)	2010-05-27
KR20070094793A (ko)	2007-09-21
US20120065258A1 (en)	2012-03-15
IL184111A0 (en)	2007-10-31
NZ556117A (en)	2009-10-30
US8084501B2 (en)	2011-12-27
CN101106973A (zh)	2008-01-16
ZA200705428B (en)	2008-09-25
JP2013056948A (ja)	2013-03-28
BRPI0606606A2 (pt)	2009-07-07
AU2006206649A1 (en)	2006-07-27

Publication	Publication Date	Title
NO20073699L (no)	2007-10-19	Stabile protaglandin-inneholdende preparater
EA200870019A1 (ru)	2008-12-30	Лактамовые соединения и способы их применения
GT200500137A (es)	2006-05-18	Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis.
NO20025601D0 (no)	2002-11-21	Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
EA200870216A1 (ru)	2009-02-27	Амидо соединения и их применение в качестве лекарственных средств
NO20064976L (no)	2006-10-31	Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
ECSP10010310A (es)	2010-07-30	Nuevos compuestos y composiciones y métodos de uso
NO20064347L (no)	2006-09-26	Substituerte 1,2,3,4-tetrahydroisokinolinderivater
NO20080141L (no)	2008-01-09	Indanderivater som modulatorer av ionekanaler
EA201001329A1 (ru)	2011-04-29	Соединения и композиции в качестве модуляторов активности gpr119
EA200970841A1 (ru)	2010-04-30	Фармацевтическое применение замещенных амидов
NO20061197L (no)	2006-05-11	Proteasominhibitorer og fremgangsmater for anvendelse av samme
EA200801492A1 (ru)	2008-10-30	Фармацевтическое применение замещенных амидов
BRPI0511111A (pt)	2007-11-27	compostos de pirrol como inibidores de cinase de proteìna de erk, sua sìntese e seus intermediários
EA201001332A1 (ru)	2011-04-29	Соединения и композиции в качестве модуляторов активности gpr119
MX2020004099A (es)	2020-07-24	Composiciones farmaceuticas que comprenden epa y un agente cardiovascular y metodos para utilizar el mismo.
EA200700118A1 (ru)	2007-08-31	Амидосоединения и их применение в качестве лекарственных средств
MY144659A (en)	2011-10-31	2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
CR11648A (es)	2010-10-05	Composicion que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes acidas
UA115131C2 (uk)	2017-09-25	Сполуки боронатного ефіру і його фармацевтичні рецептури
MY142589A (en)	2010-12-15	Benzimidazole derivatives : preparation and pharmaceutical applications
CY1108794T1 (el)	2014-04-09	Σπειροκυκλικα παραγωγα κυκλοεξανιου
EA201100138A1 (ru)	2011-08-30	4-феноксиметилпиперидины в качестве модуляторов активности gpr119
EA200870380A1 (ru)	2009-02-27	Аминотетрагидропираны в качестве ингибиторов дипептидилпептидазы-vi для лечения или предупреждения диабета
EA200802223A1 (ru)	2009-06-30	1,5-дифенилпиразолы ii в качестве ингибиторов hsp90

Legal Events

Date	Code	Title	Description
2014-08-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application